Cotchin E: Mammary neoplasms of the bitch. J Comp Pathol. 1958, 68 (1): 1-22.
Article
PubMed
Google Scholar
Moulton JE, Taylor DO, Dorn CR, Andersen AC: Canine mammary tumors. Pathol Vet. 1970, 7 (4): 289-320. 10.1177/030098587000700401.
Article
CAS
PubMed
Google Scholar
Prier JE, Brodey RS: Canine Neoplasia. A Prototype for Human Cancer Study. Bull World Health Organ. 1963, 29: 331-344.
CAS
PubMed Central
PubMed
Google Scholar
Ferreira E, Gobbi H, Saraiva BS, Cassali GD: Columnar cell lesions of the canine mammary gland: pathological features and immunophenotypic analysis. BMC Cancer. 2010, 10: 61-10.1186/1471-2407-10-61.
Article
PubMed Central
PubMed
Google Scholar
Gama A, Alves A, Schmitt F: Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Arch. 2008, 453 (2): 123-132. 10.1007/s00428-008-0644-3.
Article
CAS
PubMed
Google Scholar
Mouser P, Miller MA, Antuofermo E, Badve SS, Mohammed SI: Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease. Vet Pathol. 2010, 47 (2): 275-284. 10.1177/0300985809358603.
Article
CAS
PubMed
Google Scholar
Vinothini G, Balachandran C, Nagini S: Evaluation of molecular markers in canine mammary tumors: correlation with histological grading. Oncol Res. 2009, 18 (5-6): 193-201.
Article
CAS
PubMed
Google Scholar
Martin PM, Cotard M, Mialot JP, Andre F, Raynaud JP: Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemother Pharmacol. 1984, 12 (1): 13-17.
CAS
PubMed
Google Scholar
Strandberg JD, Goodman DG: Animal model of human disease: canine mammary neoplasia. Am J Pathol. 1974, 75 (1): 225-228.
CAS
PubMed Central
PubMed
Google Scholar
Huang CC, Liu Z, Li X, Bailey SK, Nail CD, Foster KW, Frost AR, Ruppert JM, Lobo-Ruppert SM: KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol Ther. 2005, 4 (12): 1401-1408. 10.4161/cbt.4.12.2355.
Article
CAS
PubMed
Google Scholar
Segre JA, Bauer C, Fuchs E: Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet. 1999, 22 (4): 356-360. 10.1038/11926.
Article
CAS
PubMed
Google Scholar
Shields JM, Christy RJ, Yang VW: Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem. 1996, 271 (33): 20009-20017. 10.1074/jbc.271.33.20009.
Article
CAS
PubMed Central
PubMed
Google Scholar
Turner J, Crossley M: Mammalian Kruppel-like transcription factors: more than just a pretty finger. Trends Biochem Sci. 1999, 24 (6): 236-240. 10.1016/S0968-0004(99)01406-1.
Article
CAS
PubMed
Google Scholar
Dang DT, Pevsner J, Yang VW: The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol. 2000, 32 (11-12): 1103-1121. 10.1016/S1357-2725(00)00059-5.
Article
CAS
PubMed Central
PubMed
Google Scholar
Yet SF, McA'Nulty MM, Folta SC, Yen HW, Yoshizumi M, Hsieh CM, Layne MD, Chin MT, Wang H, Perrella MA, Jain MK, Lee ME: Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem. 1998, 273 (2): 1026-1031. 10.1074/jbc.273.2.1026.
Article
CAS
PubMed
Google Scholar
Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S, Xie K: Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005, 65 (7): 2746-2754. 10.1158/0008-5472.CAN-04-3619.
Article
CAS
PubMed
Google Scholar
Choi BJ, Cho YG, Song JW, Kim CJ, Kim SY, Nam SW, Yoo NJ, Lee JY, Park WS: Altered expression of the KLF4 in colorectal cancers. Pathol Res Pract. 2006, 202 (8): 585-589. 10.1016/j.prp.2006.05.001.
Article
CAS
PubMed
Google Scholar
Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM: Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 2000, 60 (22): 6488-6495.
CAS
PubMed
Google Scholar
Foster KW, Ren S, Louro ID, Lobo-Ruppert SM, McKie-Bell P, Grizzle W, Hayes MR, Broker TR, Chow LT, Ruppert JM: Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 1999, 10 (6): 423-434.
CAS
PubMed
Google Scholar
McConnell BB, Yang VW: Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010, 90 (4): 1337-1381. 10.1152/physrev.00058.2009.
Article
CAS
PubMed Central
PubMed
Google Scholar
Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA, Krontiras H, Bland KI, LoBuglio AF, Lobo-Ruppert SM, Ruppert JM: Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res. 2004, 10 (8): 2709-2719. 10.1158/1078-0432.CCR-03-0484.
Article
CAS
PubMed
Google Scholar
Yu F, Li J, Chen H, Fu J, Ray S, Huang S, Zheng H, Ai W: Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene. 2011, 30 (18): 2161-2172. 10.1038/onc.2010.591.
Article
CAS
PubMed Central
PubMed
Google Scholar
Bruce SJ, Gardiner BB, Burke LJ, Gongora MM, Grimmond SM, Perkins AC: Dynamic transcription programs during ES cell differentiation towards mesoderm in serum versus serum-freeBMP4 culture. BMC Genomics. 2007, 8: 365-10.1186/1471-2164-8-365.
Article
PubMed Central
PubMed
Google Scholar
Zhang P, Andrianakos R, Yang Y, Liu C, Lu W: Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J Biol Chem. 2010, 285 (12): 9180-9189. 10.1074/jbc.M109.077958.
Article
CAS
PubMed Central
PubMed
Google Scholar
Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126 (4): 663-676. 10.1016/j.cell.2006.07.024.
Article
CAS
PubMed
Google Scholar
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007, 448 (7151): 318-324. 10.1038/nature05944.
Article
CAS
PubMed
Google Scholar
Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ: Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008, 451 (7175): 141-146. 10.1038/nature06534.
Article
CAS
PubMed
Google Scholar
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007, 131 (5): 861-872. 10.1016/j.cell.2007.11.019.
Article
CAS
PubMed
Google Scholar
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007, 318 (5858): 1917-1920. 10.1126/science.1151526.
Article
CAS
PubMed
Google Scholar
Misdorp W, Else RW, Hellmén E, Lipscomb TP: Histological Classification of Mammary Tumors of the Dog and Cat. Washington, D. C.: American Registry of Pathology 1999.
Google Scholar
Briffod M, Hacene K, Le Doussal V: Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases. Mod Pathol. 2000, 13 (8): 841-850. 10.1038/modpathol.3880149.
Article
CAS
PubMed
Google Scholar
Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, Braud AC, Puig B, Geneix J, Hassoun J, Birnbaum D, Jacquemier J, Viens P: Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'. J Pathol. 2004, 202 (3): 265-273. 10.1002/path.1515.
Article
PubMed
Google Scholar
Li J, Martinka M, Li G: Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis. 2008, 29 (7): 1373-1379. 10.1093/carcin/bgn086.
Article
PubMed
Google Scholar
Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F: p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005, 447 (4): 688-694. 10.1007/s00428-005-0010-7.
Article
CAS
PubMed
Google Scholar